Firm
Lawyers say attention will turn to the UK government’s AI consultation after judgment fails to match pre-trial hype
IP, M&A, life sciences and competition partners advised on deal that brings together brands such as ‘Huggies’ and ‘Kleenex’ with ‘Band-Aid’ and ‘Tylenol’
Plasseraud IP says it is eyeing AI and quantum computing expertise with new hire from Cabinet Netter
McGuireWoods’ focussed experimentation and disciplined execution of AI tools is sharpening its IP practice
Sponsored
Sponsored
-
Sponsored by Tahota Law FirmCharles Feng, Lian Xue, and Chenxi Cui of Tahota Law Firm draw on the case and several other legal disputes to explore the fractious relationship between games console emulators and manufacturers -
Sponsored by Liu, Shen & AssociatesJun Qiu of Liu, Shen & Associates analyses two recent CNIPA decisions that provide insights into the application of the good faith principle in patent re-examination and invalidation procedures in China
-
Sponsored by TOPPAN Digital IPThe team at TOPPAN Digital IP believe there are key flaws in current intellectual property systems and services. Managing IP hears how the company’s STREAM IP platform is aimed at addressing them
-
Sponsored by Liu, Shen & AssociatesDongguo Liang of Liu, Shen & Associates says DeepSeek should take swift action to address ‘insufficient planning’ in its intellectual property protection strategy and an ‘underdeveloped’ patent portfolio
-
Sponsored by Wanhuida Intellectual PropertyYue Guan of Wanhuida Intellectual Property considers the CNIPA’s evidentiary standards after its invalidation of a patent for the crystalline form of lemborexant and explains the implications for pharmaceutical patent strategies in China
-
Sponsored by Maiwald Intellectual PropertyGerman courts are now permitting the service of claims on Chinese respondents by publication to ensure effective legal protection. Marco Stief of Maiwald contrasts this approach with the Unified Patent Court’s stricter stance
